Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.

Félix Blanc-DurandGeraldine M CamilleriArnaud BayleMihaela AldeaDamien VasseurKaissa OualiJudith MichelsPatricia PautierClaudio NicotraMaud Ngo-CamusLudovic LacroixEtienne RouleauSantiago Ponce-AixAntoine ItalianoAlexandra Leary

Published in: Cancer (2024)

cfDNA sequencing in EC is a feasible approach that produces informative results in 89% of cases and accurately categorizes patients into the main molecular subclasses. It also reveals multiple actionable alterations, which offers the potential for personalized therapeutic strategies.

Keyphrases

endometrial cancer
end stage renal disease
ejection fraction
single cell
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
ionic liquid
patient reported outcomes
climate change